Zytiga, Abiraterone Abiraterone is a so-called testosterone inhibitor (testosterone inhibitor). In

Zytiga, Abiraterone Abiraterone is a so-called testosterone inhibitor (testosterone inhibitor). In contrast to the drugs that are used as part of hormone therapy (LHRH agonist), blocked abiraterone not only the testosterone production in the testes, but also in the epididymis and in the tumor tissue itself, the hormone levels reduced below the detection limit when the preparation co-administered with the LHRH agonist or is combined with a testicle removal. Zytiga is used only in conjunction with a corticosteroid hepatitis a (prednisone or prednisolone). The reason: Zytiga hepatitis a can cause in the body high blood pressure, potassium deficiency and fluid retention. The concomitant corticosteroid reduce the risk and severity of such side effects. Pack of 120 tablets for treatment hepatitis a over 3 months costs from 4.500 to 5400 euros. More about Zytiga, abiraterone effect in prostate cancer, information, opinions you read here => Prostate Cancer Guides, abiraterone.
2013 (17) December (1) January (1) January (1) January (2) June (2) January (1) April (4) Enzalutamid recommendation for approval, prostate cancer prostate cancer B. .. and immunotherapy, T cells Zytiga, abiraterone prostate cancer passive hyperthermia, self-test March (2) February (1) January (2) 2012 (1) December (1)